Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1948 2
1950 1
1951 1
1953 1
1955 1
1958 3
1959 3
1961 6
1962 2
1963 3
1964 5
1965 3
1969 4
1970 4
1971 7
1972 7
1973 6
1974 4
1975 3
1981 1
1982 1
1983 2
1986 1
1987 3
1989 1
1991 1
1992 1
1993 3
1994 3
1995 4
1996 1
1997 2
1998 1
1999 3
2000 1
2001 4
2002 4
2003 6
2004 5
2005 1
2006 4
2007 5
2008 4
2009 2
2010 2
2011 2
2013 5
2014 7
2015 5
2016 2
2017 5
2018 2
2019 2
2020 5
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial.
Fleuriet J, Heming N, Meziani F, Reignier J, Declerq PL, Mercier E, Muller G, Colin G, Monnet X, Robine A, Siami S, Uhel F, Quenot JP, Plantefeve G, Badie J, Schneider F, Cerf C, Troché G, Monchi M, Mira JP, Francois B, Chevret S, Annane D; RECORDS consortium; CRICS TRIGGERSEP network. Fleuriet J, et al. BMJ Open. 2023 Mar 10;13(3):e066496. doi: 10.1136/bmjopen-2022-066496. BMJ Open. 2023. PMID: 36898751 Free PMC article.
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Coombes RC, Badman PD, Lozano-Kuehne JP, Liu X, Macpherson IR, Zubairi I, Baird RD, Rosenfeld N, Garcia-Corbacho J, Cresti N, Plummer R, Armstrong A, Allerton R, Landers D, Nicholas H, McLellan L, Lim A, Mouliere F, Pardo OE, Ferguson V, Seckl MJ. Coombes RC, et al. Among authors: nicholas h. Nat Commun. 2023 Jan 17;14(1):260. doi: 10.1038/s41467-023-35969-4. Nat Commun. 2023. PMID: 36650166 Free PMC article. No abstract available.
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Coombes RC, Badman PD, Lozano-Kuehne JP, Liu X, Macpherson IR, Zubairi I, Baird RD, Rosenfeld N, Garcia-Corbacho J, Cresti N, Plummer R, Armstrong A, Allerton R, Landers D, Nicholas H, McLellan L, Lim A, Mouliere F, Pardo OE, Ferguson V, Seckl MJ. Coombes RC, et al. Among authors: nicholas h. Nat Commun. 2022 Jun 10;13(1):3246. doi: 10.1038/s41467-022-30666-0. Nat Commun. 2022. PMID: 35688802 Free PMC article. Clinical Trial.
Acute kidney injury: prevention, detection, and management. Summary of updated NICE guidance for adults receiving iodine-based contrast media.
Barrett T, Khwaja A, Carmona C, Martinez Y, Nicholas H, Rogers G, Wierzbicki AS, Lewington AJP; NICE Chronic Kidney Disease Guideline Development group. Barrett T, et al. Among authors: nicholas h. Clin Radiol. 2021 Mar;76(3):193-199. doi: 10.1016/j.crad.2020.08.039. Epub 2020 Dec 31. Clin Radiol. 2021. PMID: 33390251 Review.
CWN-2/Wnt regulates SMDD axonal development.
Sherry T, Nicholas HR, Pocock R. Sherry T, et al. Among authors: nicholas hr. MicroPubl Biol. 2020 Nov 25;2020:10.17912/micropub.biology.000337. doi: 10.17912/micropub.biology.000337. MicroPubl Biol. 2020. PMID: 33274317 Free PMC article. No abstract available.
169 results